Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.
- Conditions
- Post transplant anaemia in renal transplant recipients.Renal and Urogenital - Kidney disease
- Registration Number
- ACTRN12608000186358
- Lead Sponsor
- Princess Alexandra hospital (Department of nephrology)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
1.New live or cadaveric donor renal transplant recipient
2.Aged 18 years or over
3.Able to give written informed consent.
1.Patients with transferrin saturation >50% or ferritin >800µg/l.
2.Women lactating, pregnant or of child-bearing potential not using a reliable contraceptive method.
3.Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
4.Patients who have received a new investigational drug within the last 4 weeks.
5.Intolerance of intravenous or oral iron supplements
6.As the following medications can have interactive effects, they cannot be administered during the course of the study:
-All new investigational medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to normalisation of haemoglobin post renal transplant.[3 month follow up post transplant.]
- Secondary Outcome Measures
Name Time Method eed for blood transfusions.[3 month follow up post transplant.]